A Clinical Trial of TQ-A3334 Tablet After Multiple Administration in Adult Subjects

Conditions: Hepatitis B Interventions: Drug: TQ-A3334 tablets; Drug: TQ-A3334 placebo tablets Sponsors: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting

https://clinicaltrials.gov/study/NCT06160895

Source: ClinicalTrials.gov - December 7, 2023 Category: Research Source Type: clinical trials

More News: Chia | Clinical Trials | Hepatitis | Hepatitis B | Research